Benzinga | Jul 29, 2021 04:42PM EDT

Lantern Pharma Q2 EPS $(0.21) Up From $(0.31) YoY

Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.21) per share. This is a 32.26 percent increase over losses of $(0.31) per share from the same period last year.